Nobody said value investing was easy, as stocks can be undervalued for an extended period of time. This is similar to how they can be overvalued for a prolonged period, as with many AI names today.

Medtronic has launched the MiniMed 780G system in the U.S., integrated with Abbott’s Instinct sensor technology. Medtronic’s integration with Abbott was just approved by FDA in September, broadening ...

Medtronic Fails at Attempt to Escape Whistleblower Suit Under New Standard, Judge Rules "In sum, although the court previously rejected (and thus did not consider) the application of a but-for ...

Medtronic's shares have sharply rallied over the last six months. The medtech giant's growth catalysts include a best-in-class product (Affera) in a fast-growing $11 billion space and a massive ...

While there is no cure for Parkinson’s disease, there’s now a better way to control its involuntary muscle movements. In February, the FDA approved Medtronic’s BrainSense adaptive deep brain ...

Medtronic has recently affirmed a Q2 dividend of $0.71 per share, which aligns with its commitment to long-standing dividend growth and underscores its stability as an S&P 500 Dividend Aristocrat.

Medtronic is separating out its lower-margin diabetes care segment. It's also pouncing on a massive opportunity in robotic-assisted surgery. The healthcare leader has a terrific dividend-growth track ...

On Wednesday, the Centers for Medicare & Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ...

Deal Overview On May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business, while ...